Response to: 'Correspondence on 'Anti-inflammatory therapy for COVID-19 infection: the case for colchicine'' by Perricone et al

Ann Rheum Dis. 2023 Apr;82(4):e82. doi: 10.1136/annrheumdis-2021-219898. Epub 2021 Jan 28.
No abstract available

Keywords: COVID-19; inflammation; therapeutics.

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents
  • COVID-19*
  • Colchicine / therapeutic use
  • Humans
  • SARS-CoV-2

Substances

  • Colchicine
  • Anti-Inflammatory Agents